EFFICACY AND SAFETY OF DABIGATRAN ETEXILATE VERSUS VITAMIN K ANTAGONIST FOR TREATMENT OF ACUTE VENOUS THROMBOEMBOLISM IN ROUTINE CLINICAL PRACTICE: RECOVERY DVT/PE PROSPECTIVE GLOBAL COHORT STUDY

Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPGOLDHABER, SamuelAGENO, WalterCASELLA, IvanCHEE, Kok HanSCHELLONG, SebastianSINGER, Daniel E.VOCCIA, IsabelleTANG, WenboSCHULMAN, Sam2023-07-182023-07-182020JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, v.75, n.11, suppl.1, p.2195-2195, 20200735-1097https://observatorio.fm.usp.br/handle/OPI/54473engrestrictedAccessEFFICACY AND SAFETY OF DABIGATRAN ETEXILATE VERSUS VITAMIN K ANTAGONIST FOR TREATMENT OF ACUTE VENOUS THROMBOEMBOLISM IN ROUTINE CLINICAL PRACTICE: RECOVERY DVT/PE PROSPECTIVE GLOBAL COHORT STUDYconferenceObjectCopyright ELSEVIER SCIENCE INCCardiac & Cardiovascular Systems1558-3597